Australia markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.4899+0.1999 (+8.73%)
As of 12:52PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.15-0.21-0.73-0.23
Low estimate-0.22-0.23-0.77-0.55
High estimate-0.04-0.19-0.710.41
Year ago EPS-0.23-0.22-0.7-0.73
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3233
Avg. Estimate6M550k9.28M68.41M
Low estimateN/AN/AN/A26.9M
High estimate16.9M1.09M16.9M150.35M
Year ago salesN/A1.84M16.18M9.28M
Sales growth (year/est)N/A-70.10%-42.70%637.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.25-0.210.03-0.12
Actual EPS-0.23-0.22-0.21-0.05
Difference0.02-0.01-0.240.07
Surprise %8.00%-4.80%-800.00%58.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.15-0.21-0.73-0.23
7 days ago-0.15-0.22-0.73-0.23
30 days ago-0.11-0.21-0.71-0.08
60 days ago-0.2-0.2-0.59-0.26
90 days ago00-0.56-0.31
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACIUIndustrySector(s)S&P 500
Current qtr.34.80%N/AN/AN/A
Next qtr.4.50%N/AN/AN/A
Current year-4.30%N/AN/AN/A
Next year68.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A